JP2022501342A5 - - Google Patents

Info

Publication number
JP2022501342A5
JP2022501342A5 JP2021514532A JP2021514532A JP2022501342A5 JP 2022501342 A5 JP2022501342 A5 JP 2022501342A5 JP 2021514532 A JP2021514532 A JP 2021514532A JP 2021514532 A JP2021514532 A JP 2021514532A JP 2022501342 A5 JP2022501342 A5 JP 2022501342A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkyl
pharmaceutically acceptable
hydrogen
Prior art date
Application number
JP2021514532A
Other languages
English (en)
Japanese (ja)
Other versions
JP7431813B2 (ja
JP2022501342A (ja
JPWO2020061046A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/051514 external-priority patent/WO2020061046A1/en
Publication of JP2022501342A publication Critical patent/JP2022501342A/ja
Publication of JPWO2020061046A5 publication Critical patent/JPWO2020061046A5/ja
Publication of JP2022501342A5 publication Critical patent/JP2022501342A5/ja
Application granted granted Critical
Publication of JP7431813B2 publication Critical patent/JP7431813B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021514532A 2018-09-18 2019-09-17 ソマトスタチンモジュレーターとその使用 Active JP7431813B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862732735P 2018-09-18 2018-09-18
US62/732,735 2018-09-18
PCT/US2019/051514 WO2020061046A1 (en) 2018-09-18 2019-09-17 Somatostatin modulators and uses thereof

Publications (4)

Publication Number Publication Date
JP2022501342A JP2022501342A (ja) 2022-01-06
JPWO2020061046A5 JPWO2020061046A5 (https=) 2022-09-27
JP2022501342A5 true JP2022501342A5 (https=) 2022-09-27
JP7431813B2 JP7431813B2 (ja) 2024-02-15

Family

ID=69772634

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021514532A Active JP7431813B2 (ja) 2018-09-18 2019-09-17 ソマトスタチンモジュレーターとその使用

Country Status (17)

Country Link
US (4) US10696689B2 (https=)
EP (2) EP3853218B1 (https=)
JP (1) JP7431813B2 (https=)
AR (1) AR116424A1 (https=)
DK (1) DK3853218T3 (https=)
ES (1) ES3022912T3 (https=)
FI (1) FI3853218T3 (https=)
HR (1) HRP20250425T1 (https=)
HU (1) HUE071203T2 (https=)
LT (1) LT3853218T (https=)
PL (1) PL3853218T3 (https=)
PT (1) PT3853218T (https=)
RS (1) RS66720B1 (https=)
SI (1) SI3853218T1 (https=)
SM (1) SMT202500155T1 (https=)
TW (1) TWI852944B (https=)
WO (1) WO2020061046A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20221279T1 (hr) 2016-07-14 2022-12-23 Crinetics Pharmaceuticals, Inc. Modulatori somatostatina i njihove uporabe
WO2018170284A1 (en) 2017-03-16 2018-09-20 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
EP3752498B1 (en) 2018-02-12 2023-06-28 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
AR116424A1 (es) 2018-09-18 2021-05-05 Crinetics Pharmaceuticals Inc Moduladores de la somatostatina y usos de los mismos
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途
FI4210700T3 (fi) 2020-09-09 2025-09-16 Crinetics Pharmaceuticals Inc Somatostatiinimodulaatorin formulaatioita
EP4294797A1 (en) * 2021-02-17 2023-12-27 Crinetics Pharmaceuticals, Inc. Crystalline forms of a somatostatin modulator
JP2026500913A (ja) 2022-12-13 2026-01-09 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンサブタイプ-2受容体(sst2r)標的化治療薬及びその使用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127343A (en) * 1996-05-14 2000-10-03 Novo Nordisk A/S Somatostatin agonists and antagonists
US6025372A (en) 1997-04-04 2000-02-15 Merck & Co., Inc. Somatostatin agonists
FR2802206B1 (fr) 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
US20060281764A1 (en) 2005-06-10 2006-12-14 Gaul Michael D Aminopyrimidines as kinase modulators
CA2644929A1 (en) 2006-03-13 2008-05-02 Merck & Co., Inc. Somatostatin agonists
EP2054385A2 (en) 2006-08-15 2009-05-06 F. Hoffmann-Roche AG Phenyl, pyridine and quinoline derivatives
EP2211619A1 (en) 2007-10-18 2010-08-04 Merck Sharp & Dohme Corp. Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
CA2729220A1 (en) 2008-06-25 2009-12-30 Envivo Pharmaceuticals, Inc. Di-substituted phenyl compounds
GB0818241D0 (en) 2008-10-06 2008-11-12 Cancer Res Technology Compounds and their use
CA2772194A1 (en) 2009-09-01 2011-03-10 Pfizer Inc. Benzimidazole derivatives
CA2799414A1 (en) * 2010-05-18 2011-11-24 Merck Sharp & Dohme Corp. Spiro isoxazoline compounds as sstr5 antagonists
GB201008290D0 (en) 2010-05-18 2010-06-30 Syngenta Ltd Chemical compounds
WO2014007228A1 (ja) 2012-07-03 2014-01-09 小野薬品工業株式会社 ソマトスタチン受容体作動活性を有する化合物およびその医薬用途
AU2014325078B2 (en) 2013-09-30 2018-10-25 Ono Pharmaceutical Co., Ltd. Compound having agonistic activity to somatostatin receptor and medicinal use thereof
CN105579524B (zh) 2013-10-02 2018-05-04 株式会社可乐丽 树脂组合物、多层片、包装材料和容器
HRP20221279T1 (hr) 2016-07-14 2022-12-23 Crinetics Pharmaceuticals, Inc. Modulatori somatostatina i njihove uporabe
JP6838387B2 (ja) * 2016-12-21 2021-03-03 トヨタ紡織株式会社 内装部品の取付構造
CN110300749A (zh) 2017-02-08 2019-10-01 小野药品工业株式会社 具有生长抑素受体激动活性的化合物及其医药用途
WO2018170284A1 (en) 2017-03-16 2018-09-20 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
US11028068B2 (en) 2017-07-25 2021-06-08 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
EP3752498B1 (en) 2018-02-12 2023-06-28 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
AR116424A1 (es) 2018-09-18 2021-05-05 Crinetics Pharmaceuticals Inc Moduladores de la somatostatina y usos de los mismos
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途

Similar Documents

Publication Publication Date Title
JP2022501342A5 (https=)
FI3853218T3 (fi) Somatostatiinin modulaattoreita ja niiden käyttöjä
JP2016164184A5 (https=)
JP2007531744A5 (https=)
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
JP2016512844A5 (https=)
JP4324791B2 (ja) 2−アシルアミノチアゾール誘導体又はその塩
FI3759088T3 (fi) Triatsiinijohdannaiset neurotrofiineihin liittyvien sairauksien hoitamiseksi
JP2004506736A5 (https=)
HRP20170112T1 (hr) Supstituirani spojevi piridin-2-karboksamida kao kinazni inhibitori signalne regulacije apoptoze
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
RU2018113430A (ru) Производные l-фенилпирролидин-2-она в качестве ингибиторов perk
JP2013530240A5 (https=)
JP2003502272A5 (https=)
JP2004502670A5 (https=)
CA2672373A1 (en) Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
RU2010116352A (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
CA2503117A1 (en) Substituted 4-alkoxyoxazol derivatives as ppar agonists
RU2016141647A (ru) ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ
JP2017512786A5 (https=)
JP2006506380A5 (https=)
JPWO2021170109A5 (https=)
RU2014141674A (ru) 3,5-диаминопиразоловые ингибиторы киназы
JP2018521119A5 (https=)
JP2010516701A5 (https=)